Latest Pap test Stories
SAN DIEGO, Oct. 31, 2011 /PRNewswire/ -- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the US Food and Drug Administration (FDA) has approved its APTIMA HPV assay, an amplified nucleic acid test that detects high-risk strains of human papillomavirus (HPV) that are associated with cervical cancer and precancerous lesions. The test has been approved to run on Gen-Probe's fully automated, high-throughput TIGRIS instrument system. "We believe our APTIMA HPV assay will offer...
The U.S. Preventive Services Task Force (USPSTF) said healthy women between the ages of 21 to 65 should only receive a Pap smear every three years. The medical panel said it still did not have enough evidence to see the health benefits and harms of HPV testing in women older than 30. The panel maintained that a Pap smear test in women between 21 and 65 years of age "substantially" reduces the number of cervical cancer cases and deaths. The panel is highly influential in setting the...
Recommendations aim to reduce risk without reducing benefits of screening The American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) have proposed new guidelines for the prevention and early detection of cervical cancer. The proposed guidelines, which are now posted for public comment, generally advise that women reduce the number of tests they get over their lifetime to better ensure that...
SAN JOSE, Calif., Sept. 21, 2011 /PRNewswire/ -- OncoHealth Corporation, a protein biomarker diagnostics company, today announced new study data showing that the company's proprietary HPV E6 and E7 oncoprotein assays correlated with cervical disease grade and may distinguish cervical disease or cervical cancer from clinically insignificant HPV infection. These new data were shared in presentations at the 27th International Papillomavirus Conference, held this week in Berlin, Germany. The...
BEDFORD, Mass., Sept. 16, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will focus on two new, ready-to-market automated options for cervical cancer screening at the International Papillomavirus Conference & Clinical Workshop (IPV) September 17th through 22nd in Berlin, Germany....
Researchers reported that explicit inclusion of disparities in cost-effectiveness analysis, would allow policy makers to identify strategies that would reduce overall cancer risk, reduce disparities between racial ethnic subgroups, and be cost-effective, according to a study published online September 6 in the Journal of the National Cancer Institute. Disease simulation models can be used to identify effective and cost-effective strategies for reducing overall cancer incidence and...
Journalist Joan Lunden to moderate discussion about cervical cancer screening and global women's health policies ANN ARBOR, Mich., Sept. 6, 2011 /PRNewswire-USNewswire/ -- In honor of national Women's Health and Fitness Day, U-M Von Voigtlander Women's Hospital, which moves into a state-of-the-art facility in November, will host a breakfast and panel discussion at 8:30 a.m., Wed., Sept. 28, 2011 at the North Campus Research Complex, 2800 Plymouth Rd., Ann Arbor. Moderated by journalist,...
According to new CDC study in the American Journal of Obstetrics & GynecologyInvestigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest. The results of the study are published online today in the American...
SAN DIEGO, Aug. 18, 2011 /PRNewswire/ -- A forensic researcher, Lindy Hess was 32 when she was diagnosed with cervical cancer in 2005. Hess used her investigative techniques to determine what treatment would work for her. And, like half a million other Americans, she traveled outside the country for a natural approach to cancer care. According to TMD Limited, a medical tourism company, nearly 10,000 people leave the US every week to get medical treatment, and most of them travel to...
TUCSON, Ariz., July 19, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche has signed an agreement under which it will acquire 100 percent of mtm laboratories AG (mtm), a privately-held company based in Heidelberg, Germany. mtm is a global leader in developing in vitro diagnostics with a focus on early detection and diagnosis of cervical cancer, the largest early detection market in oncology. mtm...
Latest Pap test Reference Libraries
The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual...
The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual assault...
A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...
